Your shopping cart is empty!
Clinical and Laboratory Standards Institute, 11/01/2001
Publisher: CLSI
File Format: PDF
$122.00$245.21
Published:01/11/2001
Pages:16
This document provides general guidelines for performing the fibrinogen assay in the clinical laboratory. It also includes reporting of results and in vivo and in vitro conditions that may alter results. (See related publication H21-A3 in this section.)
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
Point-of-Care Blood Glucose Testing in Acute and Chronic Care Facilities; Approved Guideline, C30-A2
$148.00 $297.17
Immunoglobin and T-Cell Receptor Gene Rearrangement Assays; Approved Guideline, MM02-A2
$90.00 $180.00
A Framework for NCCLS Evaluation Protocols; A Report, EP19RE
$133.00 $266.07
Routine Urinalysis and Collection, Transportation, and Preservation of Urine Specimens; Approved Guideline, GP16-A2
$136.00 $272.67
